Lymphocytic Choriomeningitis Virus

Author(s):  
Daniel C. Pevear ◽  
Charles J. Pfau
2021 ◽  
Vol 105 ◽  
pp. 452-459
Author(s):  
Yuri Ushijima ◽  
Haruka Abe ◽  
Takehiro Ozeki ◽  
Georgelin N. Ondo ◽  
Marien J.V.M. Mbadinga ◽  
...  

2015 ◽  
Vol 35 (7) ◽  
pp. 540-553 ◽  
Author(s):  
Lubomira Lukacikova ◽  
Ingrid Oveckova ◽  
Tatiana Betakova ◽  
Katarina Laposova ◽  
Katarina Polcicova ◽  
...  

2015 ◽  
Vol 89 (22) ◽  
pp. 11734-11738 ◽  
Author(s):  
Stephanie Darbre ◽  
Susan Johnson ◽  
Sandra Kallert ◽  
Paul-Henri Lambert ◽  
Claire-Anne Siegrist ◽  
...  

Recombinant glycoprotein-deficient lymphocytic choriomeningitis virus-based vaccine vectors (rLCMV/ΔGP) are potent CD8+T cell inducers. To investigate the underlying molecular requirements, we generated a nucleoprotein-deficient vector counterpart (rLCMV/ΔNP). NP but not GP is a minimaltrans-acting factor for viral transcription and genome replication. We found that, unlike rLCMV/ΔGP, rLCMV/ΔNP failed to elicit detectable CD8+T cell responses unless NP wastranscomplemented in a transgenic host. Hence, NP-dependent intracellular gene expression is essential for LCMV vector immunogenicity.


2006 ◽  
Vol 196 (2) ◽  
pp. 79-88 ◽  
Author(s):  
Marina Gumenscheimer ◽  
Sandra Balkow ◽  
Markus M. Simon ◽  
Emilio Jirillo ◽  
Chris Galanos ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document